510(k) K210633
K210633 is an FDA 510(k) premarket notification submitted by Abbott Ireland Diagnostics Division for the device "Amylase2". The FDA issued a decision of Substantially Equivalent on May 26, 2022. The device falls under product code JFJ (Catalytic Methods, Amylase), a Class II device regulated under 21 CFR 862.1070. Abbott Ireland Diagnostics Division has 7 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 26, 2022
- Date Received
- Mar 3, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Catalytic Methods, Amylase
- Device Class
- Class II
- Regulation Number
- 862.1070
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Abbott Ireland Diagnostics Division? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.